Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid

doi:10.22541/au.162041666.65803989/v1

loading page

Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Almurtada Razok,
Abdullah Shams,
Ahmed Almeer,
Muhammad Zahid

Abstract

Guillain-Barré syndrome is an immune-mediated neuropathy that was reported following multiple vaccines. We present the case of a gentleman who developed GBS 20 days after the second dose of COVID-19 vaccination. It is important to mention that more research is needed to establish an association between COVID-19 vaccine and GBS.